Table 4. Growth rate (cm/year) among patients followed up at a growth outpatient clinic for more than six months, and results from two growth hormone stimulus tests, in São Paulo, 1997-2001.
| Test 1 | Test 2 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth rate | Normal | abnormal | total | Normal† | abnormal | total | |||||
| n | % | n | % | n | % | n | % | ||||
| Adequate | 21 | 80.8 | 05 | 19.2 | 26 (100.0) | 04 | 80.0 | 01 | 20.0 | 05 (100.0) | |
| Inadequate* | 06 | 75.0 | 02 | 25.0 | 08 (100.0) | 03 | 75.0 | 01 | 25.0 | 04 (100.0) | |
| Total ‡ | 27 | 07 | 07 | 02 | |||||||
*
Growth rates of less than 4 cm/year for non-pubertal patients and less than P3 on the Tanner curve (in accordance with sex and age) for pubertal patients were considered inadequate.11
†
The growth hormone test was considered to be normal with a peak > 10 ng/dl or Δ > 7 ng/dl.
‡
Number of patients followed up for six months or more who did the growth hormone test.